
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Tilray Inc (TLRY)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: TLRY (2-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $0.98
1 Year Target Price $0.98
4 | Strong Buy |
0 | Buy |
8 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 27.25% | Avg. Invested days 29 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.25B USD | Price to earnings Ratio - | 1Y Target Price 0.98 |
Price to earnings Ratio - | 1Y Target Price 0.98 | ||
Volume (30-day avg) 12 | Beta 2.08 | 52 Weeks Range 0.35 - 1.88 | Updated Date 09/13/2025 |
52 Weeks Range 0.35 - 1.88 | Updated Date 09/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.46 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -266.25% | Operating Margin (TTM) -6.38% |
Management Effectiveness
Return on Assets (TTM) -2.13% | Return on Equity (TTM) -88.44% |
Valuation
Trailing PE - | Forward PE 1000 | Enterprise Value 1324858098 | Price to Sales(TTM) 1.52 |
Enterprise Value 1324858098 | Price to Sales(TTM) 1.52 | ||
Enterprise Value to Revenue 1.61 | Enterprise Value to EBITDA -4.84 | Shares Outstanding 1118290048 | Shares Floating 1089759644 |
Shares Outstanding 1118290048 | Shares Floating 1089759644 | ||
Percent Insiders 0.8 | Percent Institutions 9.88 |
Upturn AI SWOT
Tilray Inc

Company Overview
History and Background
Tilray, Inc. was founded in 2018 through a reverse merger. Initially known as Tilray, its evolution includes expansion into various cannabis markets globally, strategic acquisitions, and a merger with Aphria in 2021, creating the current Tilray Brands, Inc.
Core Business Areas
- Cannabis (Medical and Recreational): Production, cultivation, distribution, and sale of medical and recreational cannabis products.
- Beverages (Alcoholic): Brewing, distilling, and distribution of alcoholic beverages, including craft beer and spirits.
- Wellness and Nutraceuticals: Production and sale of wellness products, including CBD-based products and supplements.
Leadership and Structure
Irwin D. Simon is the Chairman and CEO. The organizational structure includes various executive roles overseeing different business segments like cannabis, beverages, and international operations.
Top Products and Market Share
Key Offerings
- Cannabis Flower and Extracts: Tilray offers various cannabis flower strains and extracts. They compete with other cannabis companies like Curaleaf and Green Thumb Industries. Exact market share data fluctuates but Tilray is a significant player in Canada and Germany.
- Competitors: Curaleaf, Green Thumb Industries, Canopy Growth
- Breckenridge Distillery: Tilray owns Breckenridge Distillery. Competes with other craft spirit brands. Sales and revenues contribute to beverages sector of Tilrayu2019s earnings. Competes with brands such as Maker's Mark and Woodford Reserve.
- Competitors: Maker's Mark, Woodford Reserve, Jack Daniels
- Competitors: Boston Beer Company, New Belgium Brewing
- SweetWater Brewing Company: SweetWater is a craft beer offering. They compete with other craft breweries such as Boston Beer Company and New Belgium Brewing. It contributes significant revenue to Tilray's beer segment.
Market Dynamics
Industry Overview
The cannabis industry is rapidly evolving, driven by increasing legalization and consumer acceptance. The beverage industry, particularly craft beer and spirits, experiences growth driven by changing consumer preferences.
Positioning
Tilray is positioned as a diversified cannabis and consumer packaged goods company with a focus on growth through strategic acquisitions and expansion into new markets. It is in a period of aggressive acquisition and market consolidation.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions USD in the coming years. The alcoholic beverage market is also substantial. Tilray aims to capture significant market share in both sectors through strategic acquisitions and expansion.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio (Cannabis, beverages, wellness)
- Strong brand recognition in key markets
- Strategic acquisitions for market expansion
- Established international presence (particularly in Germany and Canada)
Weaknesses
- Inconsistent profitability
- High operating expenses
- Regulatory uncertainty in the cannabis industry
- Dilution from acquisitions
Opportunities
- Further legalization of cannabis in new markets
- Expansion into new product categories
- Increased focus on cost management
- Synergies from acquisitions
Threats
- Intense competition in the cannabis and beverage industries
- Changing consumer preferences
- Fluctuations in currency exchange rates
- Economic downturns
Competitors and Market Share
Key Competitors
- CGC
- CRON
- ACB
Competitive Landscape
Tilray faces intense competition from established cannabis companies and emerging players. Its competitive advantage lies in its diversified product portfolio and international presence. Its weaknesses are around profitability and volatile finances.
Major Acquisitions
SweetWater Brewing Company
- Year: 2020
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expansion into the craft beer market and diversification of revenue streams.
Breckenridge Distillery
- Year: 2021
- Acquisition Price (USD millions): 50
- Strategic Rationale: Entry into the craft spirits market and leverage existing distribution networks.
Growth Trajectory and Initiatives
Historical Growth: Tilray has experienced significant revenue growth through acquisitions and expansion into new markets. However, profitability has been inconsistent.
Future Projections: Analyst estimates vary widely, reflecting the uncertainty in the cannabis industry. The focus is on improved profitability through cost management and synergies from acquisitions.
Recent Initiatives: Recent initiatives include acquisitions of beverage companies, expansion into international markets, and efforts to streamline operations.
Summary
Tilray is a diversified cannabis and consumer packaged goods company aiming for growth through strategic acquisitions. While the company has achieved significant revenue growth, profitability remains a challenge. Strategic initiatives focus on expansion and cost management. The future of Tilray hinges on navigating the evolving regulatory landscape and capitalizing on market opportunities, all while facing intense competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Financial Statements
- Industry Reports
- Analyst Estimates
- Press Releases
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tilray Inc
Exchange NASDAQ | Headquaters Leamington, ON, Canada | ||
IPO Launch date 2018-07-19 | President, CEO & Chairman Mr. Irwin David Simon | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 2842 | Website https://www.tilray.com |
Full time employees 2842 | Website https://www.tilray.com |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Cruisies, Atwater Brewery, Hiball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin Beer Co., Happy Flower, Fizzy Jane's, Herb & Bloom, 420 Fizz, and Fresh Hemp Foods brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.